PATENT CLAIM ANALYSIS

Application Number: 16292011
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "364000"]

Abstract:
The invention describes compounds that inhibit both HDAC and GSK3β (i.e., HDAC/GSK3β dual inhibitors). The invention further describes compositions containing these HDAC/GSK3β dual inhibitors, as well as methods and kits using these HDAC/GSK3β dual inhibitors to treat various medical conditions. The invention also provides methods and kits using a HDAC inhibitor and a GSK3β to treat various medical conditions, and compositions containing a HDAC inhibitor and a GSK3β. Medical conditions treatable with various embodiments of the invention include but are not limited to cancers and tumors.

Claim (Index 68):
The method of  claim 67 , wherein the condition is pancreatic cancer.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 99.0
- Lexical Diversity: 1.93878
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15317559', '16012536', '14783344', '14506889', '12022977']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.77642561204614
- 35 USC 102 Novelty (BERT): 0.573986720031119
- Combined Prediction Score: 0.7561817228446379
- Mean Citation Score: 372.964488
- Max Citation Score: 610.5238
- Similarity Product: 317.1599193495989

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test